Cancer - M. F. Greaves

Cancer

(Autor)

Buch | Hardcover
288 Seiten
2000
Oxford University Press (Verlag)
978-0-19-262835-0 (ISBN)
14,95 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
Mel Greaves explains why the old paradigms of infectious diseases or genetic disorders have proved fruitless in analyzing causes of cancer, and claims that by looking at cancer in its evolutionary context, we can begin to answer some of the big questions.
Around one in three people will at some time in their lives be diagnosed with cancer. For Western societies relishing health, wealth, and longevity, its continued prominence is one of the greatest challenges to science. Cancer is extraordinarily diverse in its causation, symptoms, likelihood of effective treatment - in some sense, every patient's cancer is unique, and that is part of the problem. Mel Greaves explains why the old paradigms of infectious diseases or genetic disorders have proved fruitless, and claims that by looking at cancer in its evolutionary context, we can begin to answer some of the big questions in cancer that concern us all. Drawing on both ancient and more modern evolutionary legacies, he shows how human development has changed the rules of evolutionary games, trapping us in a nature-nurture mismatch.

Mel Greaves is Director of the Leukemia Research Fund Center at the Institute of Cancer Research, in London. The winner of several awards for cancer research, he lives in London.

Preface; PART I. CANCER: ANCIENT LEGACIES AND MODERN MYTHS; 1. Perplexed? You should be; 2. The King of Naples and other silent witnesses; 3. Questions and answers; PART II. EVOLVING CANCER; 4. Clones, clones, clones; 5. The way we are: risk and restraints; 6. How cancer cells play the winning game; 7. Green-eyed mutations?; 8. Blind chance - and ultimate extinction?; PART III. PARADOXES OF PROGRESS: INDECENT EXPOSURES; 9. Is cancer an evolutionary inevitability?; 10. And then you set fire to it?; 11. Women's troubles; 12. Men's troubles; 13. Cancer a deux; 14. Other ways of getting bugged; 15. Travelling light; 16. Dying for a living; 17. Collateral damage; 18. Finale: compounding risk with bad luck; PART IV. FINESSING THE CLONE; 19. Treatment: the blind marksman; 20. Epilogue: cancer in the 21st century; Index

Erscheint lt. Verlag 1.6.2000
Zusatzinfo 20 halftones, 20 line illustrations, index
Verlagsort Oxford
Sprache englisch
Themenwelt Sachbuch/Ratgeber Natur / Technik
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Naturwissenschaften Biologie Humanbiologie
Sozialwissenschaften Ethnologie
Sozialwissenschaften Soziologie
ISBN-10 0-19-262835-6 / 0192628356
ISBN-13 978-0-19-262835-0 / 9780192628350
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
36,00